Agenus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.

About AGEN

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.

CEO

Garo H. Armen

CEOGaro H. Armen

Employees

389

Employees389

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

1994

Founded1994

Employees

389

Employees389

AGEN Key Statistics

Market cap

114.76M

Market cap114.76M

Price-Earnings ratio

-0.47

Price-Earnings ratio-0.47

Dividend yield

—

Dividend yield—

Average volume

449.45K

Average volume449.45K

High today

$5.52

High today$5.52

Low today

$5.14

Low today$5.14

Open price

$5.19

Open price$5.19

Volume

338.97K

Volume338.97K

52 Week high

$23.40

52 Week high$23.40

52 Week low

$4.41

52 Week low$4.41

Agenus

Why Robinhood?

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. Show more

AGEN Key Statistics

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.